Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally

The Lancet

Volumn 346, Issue 8972, 1995, Pages 393-396

  Shaw, G M ^a   Wasserman, C R ^a   O'Malley, C D ^a   Tolarova, M M ^a   Lammer, E J ^b  

^a March of Dimes Birth Defects Foundation   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; MULTIVITAMIN;

ARTICLE; CEREAL; CLEFT FACE; CLEFT PALATE; CONCEPTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; FETUS; HUMAN; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MATERNAL CARE; NEURAL TUBE DEFECT; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

EID: 0029151571     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)92778-6     Document Type: Article

References (30)

1. Prevention of neural tube defects: results of the Medical Research Council vitamin study
2. Further experience of vitamin supplementation for prevention of neural tube defect recurrences
3. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects
4. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
5. Periconceptional use of multivitamins and the occurrence of neural tube defects
6. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia
7. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects
8. Periconceptional folic acid exposure and risk of occurrent neural tube defects
9. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects
10. Prevention of congenital abnormalities by periconceptional multivitamin supplementation
11. Dietary folate and non-neural midline birth defects: no evidence of an association from a case-control study in Western Australia
12. Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip
13. Orofacial clefts in Czechoslovakia: incidence, genetics and prevention of cleft lip and palate over a 19-year period
14. Birth defects monitoring in California: a resource for epidemiological research. Ped
15. Effect of supplemental vitamin therapy on the limitation of incidence of cleft lip and cleft palate in humans
16. 6 therapy
17. Effect of vitamins on human teratology
18. Vitamin supplemental as a possible factor decreasing the incidence of cleft lip/palate deformities in humans
19. The role of environmental factors in the etiology of "so-called" congenital malformations I
20. Does maternal cigarette smoking during pregnancy cause cleft lip and palate in offspring?
21. Maternal drug histories and congenital malformations: limb reduction defects and oral clefts
22. Associations between oral clefts and drugs taken during pregnancy
23. Anticonvulsants, folate levels, and pregnancy outcome: a prospective study
24. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis
25. Folate, carotene, and smoking
26. Teratogenic effects of pteroylglutamic acid deficiency in the rat. Ciba Foundation
27. Embryotoxicity of the folate antagonist methotrexate in rats and rabbits
28. Estimates of the economic costs of birth defects